Orlen (PKN) investor relations material

Executive summary

• Delivered strong operational and financial performance in Q2 and H1 2026, supported by a diversified business model, favorable macro conditions, and increased commodity prices despite market volatility and geopolitical uncertainty.

• Achieved upstream acquisitions in Norway, expansion of LNG deliveries, progress in new chemicals and Grupa Azoty Polyolefins projects, and first electricity from Baltic Power and Grudziądz CCGT.

• Loyalty program VITAY surpassed 5.6 million active users, with continued growth in non-fuel retail, electromobility, and renewable energy capacity.

• Revenue for H1 2026 reached PLN 152.2 billion, up PLN 17.8 billion year-over-year, with net profit rising to PLN 15.9 billion and EBITDA up to PLN 28.7 billion.

• Strong cash flows from operations supported capital expenditures and record dividend payments.

Financial highlights

• Q2 2026 revenue: PLN 76.5 billion; H1 2026 revenue: PLN 152.2 billion; EBITDA LIFO: PLN 13.9 billion in Q2, PLN 28.0 billion in H1.

• Net profit for Q2 2026 was PLN 7.7 billion; H1 2026 net profit at PLN 15.9 billion.

• Operating cash flow in Q2: PLN 15.2 billion; H1: PLN 23.7 billion.

• CapEx in Q2: PLN 9.3 billion; H1 CapEx: PLN 14.7 billion; full-year CapEx target: PLN 36 billion.

• Record dividend of PLN 8 per share and total dividend of PLN 9.3 billion paid in June 2026.

Outlook and guidance

• Focus on maximizing asset utilization post-maintenance, executing growth projects (Baltic Power, chemicals, LNG, Grupa Azoty Polyolefins), and maintaining financial discipline.

• The Group continues to implement its 2035 strategy, emphasizing energy transition, renewables, and business integration.

• Macro environment in Q3 remains favorable, especially in refining; long-term expectations are for normalization.

• CapEx for next 2-3 years expected in the PLN 30–40 billion range.

• Ongoing geopolitical risks and commodity price volatility are closely monitored, with risk mitigation strategies in place.